Premium
An effective chemotherapy‐free regimen of ponatinib plus venetoclax for relapsed/refractory P hiladelphia chromosome‐positive acute lymphoblastic leukemia
Author(s) -
Short Nicholas J.,
Konopleva Marina,
Kadia Tapan,
Kebriaei Partow,
Daver Naval,
Huang Xuelin,
Masarova Lucia,
Cook Robin,
Jain Nitin,
Jabbour Elias,
Kantarjian Hagop,
Ravandi Farhad
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26175
Subject(s) - ponatinib , venetoclax , dasatinib , medicine , oncology , philadelphia chromosome , chemotherapy , acute lymphocytic leukemia , regimen , hematopoietic stem cell transplantation , myeloid leukemia , leukemia , immunology , cancer research , transplantation , imatinib , chronic lymphocytic leukemia , biology , lymphoblastic leukemia , chromosomal translocation , biochemistry , gene